Oxtriphylline
Choledyl (oxtriphylline) is a small molecule pharmaceutical. Oxtriphylline was first approved as Choledyl on 1982-01-01. It is used to treat apnea, asthma, bradycardia, bronchial spasm, and bronchitis amongst others in the USA.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Oxtriphylline
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
CHOLEDYL | Pfizer | N-009268 DISCN | 1982-01-01 | 4 products |
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
apnea | HP_0002104 | D001049 | R06.81 |
asthma | EFO_0000270 | D001249 | J45 |
bradycardia | HP_0001662 | D001919 | R00.1 |
bronchial spasm | — | D001986 | — |
bronchitis | — | D001991 | J40 |
pulmonary emphysema | — | D011656 | J43 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
R: Respiratory system drugs
— R03: Drugs for obstructive airway diseases
— R03D: Other systemic drugs for obstructive airway diseases in atc
— R03DA: Xanthines, systemic for obstructive airway disease
— R03DA02: Choline theophyllinate
— R03DB: Xanthines and adrenergics
— R03DB02: Choline theophyllinate and adrenergics
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | OXTRIPHYLLINE |
INN | choline theophyllinate |
Description | Choline theophyllinate (INN), also known as oxtriphylline, is a cough medicine derived from xanthine that acts as a bronchodilator to open up airways in the lung. Chemically, it is a salt of choline and theophylline. It classifies as an expectorant. The drug is available under the brand names Choledyl and Choledyl SA, among others.
|
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | C[N+](C)(C)CCO.Cn1c(=O)c2[n-]cnc2n(C)c1=O |
Identifiers
PDB | — |
CAS-ID | 4499-40-5 |
RxCUI | 20976 |
ChEMBL ID | CHEMBL1200434 |
ChEBI ID | — |
PubChem CID | 656652 |
DrugBank | DB01303 |
UNII ID | 3K045XR58X (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 202 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
52 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more